Remove Drug Pricing Remove Generic Medicine Remove Pharmaceutical Companies
article thumbnail

STAT+: U.S. Patent Office pulls controversial rule to curb pharma patent abuse

STAT

Patent & Trademark Office has withdrawn a controversial proposal that was designed to prevent pharmaceutical companies from abusing the patent system.

article thumbnail

STAT+: Under pressure to thwart pharma patent abuse, the PTO proposes a new rule. But will it fly?

STAT

Patent and Trademark Office has proposed a new rule designed to stem the use of so-called patent thickets , which are wielded by pharmaceutical companies to delay the arrival of lower-cost generic medicines in the marketplace. In a bid to prevent the patent system from being abused, the U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Is India capable of ensuring equitable access to biopharmaceuticals?

Express Pharma

In a bid to resolve both physical and financial restrictions inhibiting equitable access to quality medicines, the Jan Aushadhi scheme was launched in 2008 and envisaged the setting up of dedicated Janaushadhi Kendras to provide quality generic medicines at capped prices for the general public.

article thumbnail

STAT+: Pharmalittle: We’re reading about a new schizophrenia drug, a U.N. pledge on AMR and more

STAT

It is a new type of medicine that works by stimulating a pair of muscarinic receptors in the brain, that, in turn, control the release of a brain chemical called acetylcholine. Current antipsychotics, which include generic medicines and branded products,  mostly regulate mood by blocking dopamine receptors.